Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportNeurosciences - Clinical Neurosciences (including neuro-oncology)

Astrogliosis marker [11C]SL2511.88 After COVID-19 With Ongoing Depressive and Cognitive Symptoms

Joeffre Braga, Jie Yi Kuik, Mariel Lepra, Pablo Rusjan, Stephen Kish, Erica Vieira, Zahra Nasser, Natasha Verhoeff, Neil Vasdev, Thomas Chao, Michael Bagby, Isabelle Boileau, Stefan Kloiber, Ishrat Husain, Nathan Kolla, Yuko Koshimori, Khunsa Faiz, Wei Wang and Jeffrey Meyer
Journal of Nuclear Medicine June 2024, 65 (supplement 2) 241475;
Joeffre Braga
1University of Toronto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jie Yi Kuik
1University of Toronto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mariel Lepra
1University of Toronto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pablo Rusjan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Kish
2Brain Health Imaging Centre, CAMH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erica Vieira
3Centre for Addiction and Mental Health (CAMH), University of Toronto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zahra Nasser
4Centre for Addiction and Mental Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natasha Verhoeff
4Centre for Addiction and Mental Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neil Vasdev
5CAMH Brain Health Imaging Centre
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Chao
6University of British Columbia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Bagby
1University of Toronto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabelle Boileau
2Brain Health Imaging Centre, CAMH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefan Kloiber
7CAMH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ishrat Husain
7CAMH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathan Kolla
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuko Koshimori
4Centre for Addiction and Mental Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Khunsa Faiz
8Hamilton Health Sciences, McMaster University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wei Wang
4Centre for Addiction and Mental Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey Meyer
7CAMH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

241475

Introduction: After acute COVID-19, persistent depressive and cognitive symptoms occur in ~5% of cases (COVID-DC). Theoretical models of COVID-DC suggest astrogliosis is important but measures primarily indicative of astrogliosis have not been studied in COVID-DC.

Methods: In this case-control study, positron emission tomography (PET) is used to determine if [11C]SL2511.88 total distribution volume (), an index of monoamine oxidase B (MAO-B) density and marker of astrogliosis (outside midbrain) is elevated in COVID-DC. In 21 COVID-DC cases and 21 healthy controls [11C]SL2511.88 VT was measured in prefrontal cortex (PFC), anterior cingulate cortex (ACC), hippocampus, dorsal putamen (DP) and ventral striatum (VS). Depressive and cognitive symptoms were measured with psychological and neuropsychological tests. Data collection and analysis for participants with current major depressive episode without history of COVID-19 is ongoing; n=21 is anticipated at the time of presentation.

Results: [11C]SL2511.88 VT was greater in COVID-DC compared to healthy across prioritized regions by ~20% (p=0.001), as well as most grey matter regions. MDE severity, measured by the Beck Depression Inventory-2 negatively correlated with [11C]SL2511.88 VT in PFC, ACC, DP and VS, r=-0.55 (p=0.02) to -0.48 (p=0.04)). The 10 least severe COVID-DC cases had higher [11C]SL2511.88 VT than the 9 most severe across regions of interest by 18% (p=0.01). More recent acute COVID-19 correlated with greater [11C]SL2511.88 VT, r=0.61 (p=0.003) to 0.74 (p=0.0001), reflecting higher values since predominance of the omicron variant.

Conclusions: MAO-B labelled astrogliosis occurs throughout grey matter regions in COVID-DC. However, greater astrogliosis associated with lesser symptom severity, raising the possibility of a protective role in COVID-DC, such as combatting infection. Degree of astrogliosis in COVID-DC has not decreased since emergence of omicron variant.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 65, Issue supplement 2
June 1, 2024
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Astrogliosis marker [11C]SL2511.88 After COVID-19 With Ongoing Depressive and Cognitive Symptoms
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Astrogliosis marker [11C]SL2511.88 After COVID-19 With Ongoing Depressive and Cognitive Symptoms
Joeffre Braga, Jie Yi Kuik, Mariel Lepra, Pablo Rusjan, Stephen Kish, Erica Vieira, Zahra Nasser, Natasha Verhoeff, Neil Vasdev, Thomas Chao, Michael Bagby, Isabelle Boileau, Stefan Kloiber, Ishrat Husain, Nathan Kolla, Yuko Koshimori, Khunsa Faiz, Wei Wang, Jeffrey Meyer
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 241475;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Astrogliosis marker [11C]SL2511.88 After COVID-19 With Ongoing Depressive and Cognitive Symptoms
Joeffre Braga, Jie Yi Kuik, Mariel Lepra, Pablo Rusjan, Stephen Kish, Erica Vieira, Zahra Nasser, Natasha Verhoeff, Neil Vasdev, Thomas Chao, Michael Bagby, Isabelle Boileau, Stefan Kloiber, Ishrat Husain, Nathan Kolla, Yuko Koshimori, Khunsa Faiz, Wei Wang, Jeffrey Meyer
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 241475;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Is TSPO PET imaging in multiple sclerosis supported by the existing evidence? a systematic review and meta-analysis.
  • Review of the updated American Academy of Neurology (AAN) consensus guideline for determination of pediatric and adult brain death/death by neurologic criteria (BD/DNC) - implications for nuclear medicine practitioners.
  • Impaired Cerebrospinal Fluid 18F-FEPPA Clearance in Long COVID Suggests Altered Glymphatic System Function
Show more Neurosciences - Clinical Neurosciences (including neuro-oncology)

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire